Showing results (1-10 of 83) with videos related to
Sort By:
Pageof 9
Health Economics|January 16, 2004
Cost-effectiveness analysis and health care resource allocation: decision rules under variable returns to scaleElamin H Elbasha, Mark L MessonnierHealth Economics|September 24, 2004
Risk aversion and uncertainty in cost-effectiveness analysis: the expected-utility, moment-generating function approachElamin H ElbashaBulletin of Mathematical Biology|November 14, 2007
Global stability of equilibria in a two-sex HPV vaccination modelElamin H ElbashaHealth Economics|February 4, 2003
Deadweight loss of bacterial resistance due to overtreatmentElamin H ElbashaPharmacoeconomics|February 9, 2022
Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility ApproachesElamin H ElbashaMathematical Biosciences and Engineering : MBE|August 3, 2013
Model for hepatitis C virus transmissionsElamin H ElbashaPharmacoeconomics|April 9, 2015
Characterizing Heterogeneity Bias in Cohort-Based ModelsElamin H Elbasha, Jagpreet ChhatwalMedical Decision Making : an International Journal of the Society for Medical Decision Making|June 21, 2015
Theoretical Foundations and Practical Applications of Within-Cycle Correction MethodsElamin H Elbasha, Jagpreet ChhatwalPharmacoeconomics|December 9, 2015
Myths and Misconceptions of Within-Cycle Correction: A Guide for Modelers and Decision MakersElamin H Elbasha, Jagpreet ChhatwalVaccine|August 18, 2010
Impact of vaccinating boys and men against HPV in the United StatesElamin H Elbasha, Erik J DasbachPageof 9